(Q24186770)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25879092%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

0 references

1 reference

title

Chemotherapy for children with medulloblastoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25879092%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25879092%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Geert O Janssens

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25879092%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Elvira C van Dalen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25879092%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Erna M C Michiels

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25879092%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Antoinette Y N Schouten-Van Meeteren

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25879092%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

1 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25879092%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

5 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25879092%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25879092%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

CD006678

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25879092%20AND%20SRC:MED&resulttype=core&format=json

Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II.

5 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

[Medulloblastoma study of the German Society for Pediatric Oncology, a first report]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

[Medulloblastoma therapy studies MBL 80 and MED 84 of the Society of Pediatric Oncology and the Société Internationale d'Oncologie Pédiatrique (SIOP)]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Prospective randomized cooperative medulloblastoma trial (MED 84) of the International Society of Paediatric Oncology (SIOP) and of the (German) Society of Paediatric Oncology (GPO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Comparison of permanent hair loss in children with standard risk PNETS of the posterior fossa following radiotherapy alone or chemotherapy and radiotherapy after surgical resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

"Large cell/anaplastic" medulloblastomas: a Pediatric Oncology Group Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Reduction of health status 7 years after addition of chemotherapy to craniospinal irradiation for medulloblastoma: a follow-up study in PNET 3 trial survivors on behalf of the CCLG (formerly UKCCSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Neurocognitive development of children after a cerebellar tumor in infancy: A longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Medulloblastoma with extensive nodularity: a variant with favorable prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Statistical considerations in the intent-to-treat principle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Endocrine disorders following treatment of childhood brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Medulloblastoma comprises four distinct molecular variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

High-dose chemotherapy with autologous stem cell rescue as first line of treatment in young children with medulloblastoma and supratentorial primitive neuroectodermal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Treatment of early childhood medulloblastoma by postoperative chemotherapy alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Hypothalamo-pituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Molecular subgroups of medulloblastoma: the current consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Chemotherapy for children with medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

Analysis of clinical trials by treatment actually received: is it really an option?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006678.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/14651858.CD006678.PUB2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25879092%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference